Russell Investments Group Ltd. Cuts Stake in Hims & Hers Health, Inc. $HIMS

Key Points

• Russell Investments Group Ltd. significantly reduced its holdings in Hims & Hers Health by 80.8% during the first quarter, now owning 26,443 shares valued at approximately $781,000.
• Despite a 72.6% year-over-year revenue increase to $544.83 million, Hims & Hers Health reported an earnings miss for the last quarter, with $0.17 EPS against a consensus estimate of $0.18 EPS.
• Analysts have mixed opinions on the stock, with an average target price of $38.92, including two "Buy," eight "Hold," and three "Sell" ratings.

Russell Investments Group Ltd. reduced its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 80.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,443 shares of the company's stock after selling 110,939 shares during the quarter. Russell Investments Group Ltd.'s holdings in Hims & Hers Health were worth $781,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Signaturefd LLC boosted its holdings in Hims & Hers Health by 17.7% during the 1st quarter. Signaturefd LLC now owns 2,586 shares of the company's stock valued at $76,000 after acquiring an additional 388 shares during the period. GAMMA Investing LLC lifted its position in Hims & Hers Health by 128.5% in the first quarter. GAMMA Investing LLC now owns 5,143 shares of the company's stock valued at $152,000 after purchasing an additional 2,892 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Hims & Hers Health by 95.2% during the first quarter. New York State Teachers Retirement System now owns 194,795 shares of the company's stock valued at $5,756,000 after purchasing an additional 94,983 shares during the period. BNP Paribas Financial Markets bought a new position in shares of Hims & Hers Health in the fourth quarter worth approximately $1,230,000. Finally, Fifth Third Bancorp grew its holdings in shares of Hims & Hers Health by 165.4% in the first quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock worth $46,000 after purchasing an additional 961 shares during the last quarter. Institutional investors own 63.52% of the company's stock.

Insider Activity at Hims & Hers Health

In other news, CFO Oluyemi Okupe sold 11,581 shares of the company's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $43.69, for a total value of $505,973.89. Following the sale, the chief financial officer directly owned 116,806 shares of the company's stock, valued at $5,103,254.14. This represents a 9.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Soleil Boughton sold 2,571 shares of the stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $44.53, for a total transaction of $114,486.63. Following the completion of the transaction, the insider owned 150,450 shares of the company's stock, valued at approximately $6,699,538.50. The trade was a 1.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,395,428 shares of company stock valued at $71,753,898 over the last ninety days. Insiders own 13.71% of the company's stock.

Hims & Hers Health Trading Down 4.0%

Shares of NYSE HIMS traded down $1.76 during midday trading on Friday, hitting $42.36. 16,080,388 shares of the company traded hands, compared to its average volume of 29,952,310. Hims & Hers Health, Inc. has a 12-month low of $13.47 and a 12-month high of $72.98. The firm has a market cap of $9.57 billion, a P/E ratio of 52.95, a P/E/G ratio of 2.98 and a beta of 2.08. The stock has a 50-day moving average price of $49.98 and a 200 day moving average price of $45.82. The company has a debt-to-equity ratio of 1.72, a quick ratio of 4.46 and a current ratio of 4.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. The firm had revenue of $544.83 million for the quarter, compared to the consensus estimate of $550.06 million. During the same period in the previous year, the firm posted $0.06 earnings per share. The business's revenue was up 72.6% compared to the same quarter last year. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently commented on HIMS shares. UBS Group set a $30.00 price target on shares of Hims & Hers Health in a report on Monday, June 23rd. Morgan Stanley restated an "equal weight" rating and issued a $40.00 price objective on shares of Hims & Hers Health in a research report on Wednesday, June 11th. Zacks Research downgraded shares of Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 19th. Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a research note on Tuesday, August 5th. Finally, Piper Sandler restated a "neutral" rating and set a $39.00 price target (up previously from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Reduce" and an average price target of $38.92.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.